Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
"Dividend policy remains stable": CVS Health Board of Directors has approved a quarterly cash dividend of $0.665 per common share.

"Dividend policy remains stable": CVS Health Board of Directors has approved a quarterly cash dividend of $0.665 per common share.

老虎证券老虎证券2026/03/18 21:36
Show original
This dividend is consistent with the previous quarter, maintaining the company's usual payout level. **Dividend Record Demonstrates Financial Strength** As one of the largest healthcare service providers in the United States, CVS Health has maintained a stable dividend payment record for over a decade. Even during the pandemic, the company continued its quarterly payouts, demonstrating strong cash flow and financial resilience. Currently, the company's dividend yield is about 3.5%, higher than the S&P 500 average of 1.6%. **Diversified Business Supports Cash Flow** CVS Health generates stable revenue through its three main business segments: retail pharmacy, pharmacy benefit management (PBM), and health insurance. According to the Q4 2023 financial report, the company's revenue reached $93.5 billions, up 12% year-on-year. Management expects adjusted earnings per share for 2024 to be between $8.50 and $8.70, providing a solid foundation for continued dividend payments. **Industry Comparison and Investor Preference** In the healthcare sector, CVS Health's dividend policy is relatively conservative but reliable. Compared to its peers, its payout ratio remains at a moderate level of around 25%, ensuring shareholder returns while leaving room for business expansion. In the current interest rate environment, stable dividend-yielding stocks are favored by long-term investors.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53

BUZZ - After an upgrade by Citi, Australia's QBE Insurance may see its best week in four months

On October 9, shares of Australian QBE Insurance Group (QBE.AX) continued their upward trend, rising 1.8% to AUD 24.805, reaching the highest level since August 5. The stock has gained approximately 4.2% this week and is on track for its best weekly performance since early June. Earlier this week, Citi noted in a report that the insurer stands out from its domestic peers due to its ability to achieve at least mid-single-digit, volume-driven gross written premium (GWP) growth while maintaining underwriting margins. The broker upgraded the stock's rating to "Buy" and raised its target price by 10.3% to AUD 26.70. The report also stated that QBE has currently reached a total premium income of USD 1.5 billions and is expected to increase to USD 2.5 billions in the medium term. Citi added that it remains optimistic about the stock thanks to enhanced earnings stability brought by prudent reserving. So far this year, QBE shares have risen about 25%.

路透社•2026/10/09 03:51

Deutsche Bank estimates the impact of rising interest rates: US major banks face capital pressure, and stock buybacks may collectively hit the brakes.

Deutsche Bank recently released an industry research report focusing on the capital pressure faced by large US banks amid a significant rise in interest rates expected in Q3 2026.

智通财经•2026/10/09 03:42